-
Tetrandrine: Research Uses, Mechanism & Handling
2026-09-27
Tetrandrine is a natural-product alkaloid used as a research probe for calcium-channel modulation and related signaling questions. Its product specifications support practical guidance on formulation and storage, while the cited SARS-CoV-2 NSP15 screening study does not establish tetrandrine as an antiviral hit.
-
Necrostatin-1 (Nec-1): Assay Guide
2026-09-26
This practical guide explains how to use Necrostatin-1 (Nec-1), SKU A4213, to investigate RIP1-dependent necroptosis while managing solvent, dose, and interpretation challenges. It distinguishes product-reported activity values from workflow starting points and shows why viability results should be supported by pathway-specific evidence.
-
TRPV1+ Sensory Nerves Suppress Inflammation
2026-09-26
Song and colleagues report that stimulating TRPV1+ sensory afferents at the nape engages brainstem and autonomic pathways that suppress systemic inflammatory responses. The study links peripheral sensory input to catecholamine release and splenic gene-expression changes, while highlighting important limits on generalizing this neural mechanism to other inflammatory models.
-
MK-571 (L-660,711): Assay Workflows
2026-09-25
Use MK-571 to test cysteinyl leukotriene receptor signaling in functional airway models, while keeping its separate MRP1 activity in view. This workflow pairs practical dosing and vehicle controls with a careful comparison to a recent study of transporter-mediated changes in quercetin exposure.
-
RNAi Reveals SARS-CoV-2 Release Factors
2026-09-25
Kerr et al. used an arrayed RNA interference screen and virus-production measurements at two timepoints to identify host pathways that support SARS-CoV-2 replication, including vesicle-mediated transport linked to viral release. Validation across the original virus and Delta and Omicron variants, together with inhibition of Rab11a-mediated cargo delivery by CDKI-73, points to host-directed antiviral hypotheses while leaving important questions about specificity and therapeutic transferability.
-
Parthenolide and ROS-Linked Apoptosis in Lymphoid Cancer
2026-09-24
Across seven lymphoid malignancy cell lines, parthenolide reduced resazurin-measured metabolic activity and was associated with apoptosis, increased reactive oxygen species, glutathione depletion, and loss of mitochondrial membrane potential. The study’s value lies in combining this cross-disease cell panel with redox and cell-death measurements, while its in vitro findings call for careful interpretation of metabolic readouts and further mechanistic validation.
-
Nanoparticle Uptake by Human Corneal Epithelial Cells
2026-09-24
Azadi and David examined how PLGA nanoparticle size and surface modification affect uptake by human corneal epithelial cells in a model that includes simulated mucosal conditions. Their results identify energy-dependent endocytosis—especially macropinocytosis and caveolae-mediated uptake—as dominant routes, while showing that uptake depends on both particle size and surface chemistry.
-
Gentamycin Sulfate in Resistance Assay Design
2026-09-23
Discover how Gentamycin Sulfate can function as a mechanistic phenotype probe in bacterial protein synthesis research and plasmid-mediated resistance studies. This guide translates recent carbapenem-resistant Enterobacter cloacae findings into practical assay design, controls, and interpretation strategies.
-
Dinaciclib: A Temporal CDK Perturbation Tool
2026-09-23
Dinaciclib (SCH727965) can do more than suppress proliferation: it enables time-resolved analysis of how CDK activity, apoptosis, and tissue mechanics interact. This article translates a 2026 Drosophila boundary study into a cautious, mechanics-aware framework for cancer research.
-
BBB Permeability Prediction with Lysosomal Correction
2026-09-22
The reference study develops a high-throughput surrogate blood-brain barrier model by combining LLC-PK1-MOCK and LLC-PK1-MDR1 Transwell cultures with a lysosomal trapping correction. Its correlation with unbound brain-to-plasma distribution and successful validation across structurally diverse compounds support a practical workflow for prioritizing CNS drug candidates before extensive in vivo testing.
-
Transcription Condensates Safeguard Genome Stability
2026-09-21
Marmolejo and colleagues show that transcription condensates at histone locus bodies are formed and dissolved at defined points in S phase by cell-cycle and checkpoint kinases. This mechanism coordinates linker histone expression with DNA replication, revealing how condensate timing prevents genome-wide DNA damage.
-
Necrostatin-1: RIP1 Kinase Inhibitor Workflows
2026-09-21
Learn how to use Necrostatin-1 as a mechanistic probe for necroptosis, RIP1 kinase signaling, inflammatory injury, and acute kidney injury research. This workflow-focused guide connects dose selection, orthogonal validation, ferroptosis-aware interpretation, and troubleshooting for more reproducible experiments.
-
Notch Inhibition Sensitizes TNBC to Checkpoint Blockade
2026-09-20
Shen et al. show that aberrant Notch activity in triple-negative breast cancer reshapes the tumor immune microenvironment through cytokine-dependent recruitment of tumor-associated macrophages. Their preclinical data indicate that suppressing this program before immune checkpoint blockade can increase cytotoxic T-cell activity and markedly reduce lung metastasis.
-
ETS1–SENP2 Control of Mitophagy in BPD
2026-09-19
The reference study identifies ETS1 as a transcriptional regulator of mitochondrial quality control in hyperoxia-induced bronchopulmonary dysplasia, connecting SENP2 expression with FUNDC1 deSUMOylation, HSPA8 binding, and FUNDC1 degradation. Its findings clarify a SUMO-regulated mitophagy pathway, while also defining important limits for translating this mechanism into chemical-inhibitor studies.
-
Protease Inhibitor Cocktail: EDTA-Free Use
2026-09-19
Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) helps limit proteolytic loss during protein extraction and downstream assays, including Western blotting, co-immunoprecipitation, and kinase workflows. Its EDTA-free composition suits divalent-cation-sensitive applications, but it should not be treated as an EDTA-based metalloprotease inhibitor or used without checking DMSO compatibility.